1 Market Overview
1.1 Specialty Pharmaceutical Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Specialty Pharmaceutical Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Antibody
1.2.3 Hormone
1.2.4 Growth Factors
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Specialty Pharmaceutical Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Global Specialty Pharmaceutical Market Size & Forecast
1.4.1 Global Specialty Pharmaceutical Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Specialty Pharmaceutical Sales in Volume (2017-2028)
1.4.3 Global Specialty Pharmaceutical Price (2017-2028)
1.5 Global Specialty Pharmaceutical Production Capacity Analysis
1.5.1 Global Specialty Pharmaceutical Total Production Capacity (2017-2028)
1.5.2 Global Specialty Pharmaceutical Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Specialty Pharmaceutical Market Drivers
1.6.2 Specialty Pharmaceutical Market Restraints
1.6.3 Specialty Pharmaceutical Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Specialty Pharmaceutical Product and Services
2.1.4 Pfizer Specialty Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Specialty Pharmaceutical Product and Services
2.2.4 Roche Specialty Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business
2.3.3 Amgen Specialty Pharmaceutical Product and Services
2.3.4 Amgen Specialty Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business
2.4.3 AbbVie Specialty Pharmaceutical Product and Services
2.4.4 AbbVie Specialty Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Novo Nordisk
2.5.1 Novo Nordisk Details
2.5.2 Novo Nordisk Major Business
2.5.3 Novo Nordisk Specialty Pharmaceutical Product and Services
2.5.4 Novo Nordisk Specialty Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Specialty Pharmaceutical Product and Services
2.6.4 Johnson & Johnson Specialty Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sanofi-Aventis
2.7.1 Sanofi-Aventis Details
2.7.2 Sanofi-Aventis Major Business
2.7.3 Sanofi-Aventis Specialty Pharmaceutical Product and Services
2.7.4 Sanofi-Aventis Specialty Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Specialty Pharmaceutical Product and Services
2.8.4 Merck Specialty Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Specialty Pharmaceutical Product and Services
2.9.4 Eli Lilly Specialty Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Specialty Pharmaceutical Product and Services
2.10.4 Novartis Specialty Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 3sbio
2.11.1 3sbio Details
2.11.2 3sbio Major Business
2.11.3 3sbio Specialty Pharmaceutical Product and Services
2.11.4 3sbio Specialty Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Changchun High Tech
2.12.1 Changchun High Tech Details
2.12.2 Changchun High Tech Major Business
2.12.3 Changchun High Tech Specialty Pharmaceutical Product and Services
2.12.4 Changchun High Tech Specialty Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 CP Guojian Pharmacy
2.13.1 CP Guojian Pharmacy Details
2.13.2 CP Guojian Pharmacy Major Business
2.13.3 CP Guojian Pharmacy Specialty Pharmaceutical Product and Services
2.13.4 CP Guojian Pharmacy Specialty Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Biotech Pharma
2.14.1 Biotech Pharma Details
2.14.2 Biotech Pharma Major Business
2.14.3 Biotech Pharma Specialty Pharmaceutical Product and Services
2.14.4 Biotech Pharma Specialty Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Gelgen Biopharma
2.15.1 Gelgen Biopharma Details
2.15.2 Gelgen Biopharma Major Business
2.15.3 Gelgen Biopharma Specialty Pharmaceutical Product and Services
2.15.4 Gelgen Biopharma Specialty Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Innovent
2.16.1 Innovent Details
2.16.2 Innovent Major Business
2.16.3 Innovent Specialty Pharmaceutical Product and Services
2.16.4 Innovent Specialty Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Specialty Pharmaceutical Breakdown Data by Manufacturer
3.1 Global Specialty Pharmaceutical Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Specialty Pharmaceutical Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Specialty Pharmaceutical
3.4 Market Concentration Rate
3.4.1 Top 3 Specialty Pharmaceutical Manufacturer Market Share in 2021
3.4.2 Top 6 Specialty Pharmaceutical Manufacturer Market Share in 2021
3.5 Global Specialty Pharmaceutical Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Specialty Pharmaceutical Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Specialty Pharmaceutical Market Size by Region
4.1.1 Global Specialty Pharmaceutical Sales in Volume by Region (2017-2028)
4.1.2 Global Specialty Pharmaceutical Revenue by Region (2017-2028)
4.2 North America Specialty Pharmaceutical Revenue (2017-2028)
4.3 Europe Specialty Pharmaceutical Revenue (2017-2028)
4.4 Asia-Pacific Specialty Pharmaceutical Revenue (2017-2028)
4.5 South America Specialty Pharmaceutical Revenue (2017-2028)
4.6 Middle East and Africa Specialty Pharmaceutical Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Specialty Pharmaceutical Sales in Volume by Type (2017-2028)
5.2 Global Specialty Pharmaceutical Revenue by Type (2017-2028)
5.3 Global Specialty Pharmaceutical Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Specialty Pharmaceutical Sales in Volume by Application (2017-2028)
6.2 Global Specialty Pharmaceutical Revenue by Application (2017-2028)
6.3 Global Specialty Pharmaceutical Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Specialty Pharmaceutical Sales by Type (2017-2028)
7.2 North America Specialty Pharmaceutical Sales by Application (2017-2028)
7.3 North America Specialty Pharmaceutical Market Size by Country
7.3.1 North America Specialty Pharmaceutical Sales in Volume by Country (2017-2028)
7.3.2 North America Specialty Pharmaceutical Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Specialty Pharmaceutical Sales by Type (2017-2028)
8.2 Europe Specialty Pharmaceutical Sales by Application (2017-2028)
8.3 Europe Specialty Pharmaceutical Market Size by Country
8.3.1 Europe Specialty Pharmaceutical Sales in Volume by Country (2017-2028)
8.3.2 Europe Specialty Pharmaceutical Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Specialty Pharmaceutical Sales by Type (2017-2028)
9.2 Asia-Pacific Specialty Pharmaceutical Sales by Application (2017-2028)
9.3 Asia-Pacific Specialty Pharmaceutical Market Size by Region
9.3.1 Asia-Pacific Specialty Pharmaceutical Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Specialty Pharmaceutical Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Specialty Pharmaceutical Sales by Type (2017-2028)
10.2 South America Specialty Pharmaceutical Sales by Application (2017-2028)
10.3 South America Specialty Pharmaceutical Market Size by Country
10.3.1 South America Specialty Pharmaceutical Sales in Volume by Country (2017-2028)
10.3.2 South America Specialty Pharmaceutical Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Specialty Pharmaceutical Sales by Type (2017-2028)
11.2 Middle East & Africa Specialty Pharmaceutical Sales by Application (2017-2028)
11.3 Middle East & Africa Specialty Pharmaceutical Market Size by Country
11.3.1 Middle East & Africa Specialty Pharmaceutical Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Specialty Pharmaceutical Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Specialty Pharmaceutical and Key Manufacturers
12.2 Manufacturing Costs Percentage of Specialty Pharmaceutical
12.3 Specialty Pharmaceutical Production Process
12.4 Specialty Pharmaceutical Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Specialty Pharmaceutical Typical Distributors
13.3 Specialty Pharmaceutical Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
世界の特殊医薬品市場2022年：市場規模予測（～2028年） |
| 【英語タイトル】Global Specialty Pharmaceutical Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 | |
 | ・商品コード：GIR22DC3938 ・発行会社（調査会社）：GlobalInfoResearch ・発行日：2023年1月 ・ページ数：116 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（注文後2-3日） ・調査対象地域：グローバル ・産業分野：医薬品 |
| Single User（1名様閲覧用） | USD3,480 ⇒換算￥528,960 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD5,220 ⇒換算￥793,440 | 見積依頼/購入/質問フォーム |
| Corporate User（同一法人内共有可） | USD6,960 ⇒換算￥1,057,920 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 特殊医薬品市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の特殊医薬品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 特殊医薬品市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・抗体、ホルモン、成長因子、その他 用途別セグメントは次のように区分されます。 ・腫瘍、糖尿病、循環器、血友病、その他 世界の特殊医薬品市場の主要な市場プレーヤーは以下のとおりです。 ・Pfizer、Roche、Amgen、AbbVie、Novo Nordisk、Johnson & Johnson、Sanofi-Aventis、Merck、Eli Lilly、Novartis、3sbio、Changchun High Tech、CP Guojian Pharmacy、Biotech Pharma、Gelgen Biopharma、Innovent 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、特殊医薬品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な特殊医薬品メーカーの企業概要、2019年～2022年までの特殊医薬品の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な特殊医薬品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別特殊医薬品の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの特殊医薬品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での特殊医薬品市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および特殊医薬品の産業チェーンを掲載しています。 ・第13、14、15章では、特殊医薬品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 特殊医薬品の概要 - 種類別分析（2017年vs2021年vs2028年）：抗体、ホルモン、成長因子、その他 - 用途別分析（2017年vs2021年vs2028年）：腫瘍、糖尿病、循環器、血友病、その他 - 世界の特殊医薬品市場規模・予測 - 世界の特殊医薬品生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Pfizer、Roche、Amgen、AbbVie、Novo Nordisk、Johnson & Johnson、Sanofi-Aventis、Merck、Eli Lilly、Novartis、3sbio、Changchun High Tech、CP Guojian Pharmacy、Biotech Pharma、Gelgen Biopharma、Innovent ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：抗体、ホルモン、成長因子、その他 ・用途別分析2017年-2028年：腫瘍、糖尿病、循環器、血友病、その他 ・特殊医薬品の北米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・特殊医薬品のヨーロッパ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・特殊医薬品のアジア市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・特殊医薬品の南米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・特殊医薬品の中東・アフリカ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Specialty Pharmaceutical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Specialty Pharmaceutical market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Tumor accounting for % of the Specialty Pharmaceutical global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Antibody segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Specialty Pharmaceutical include Pfizer, Roche, Amgen, AbbVie, and Novo Nordisk, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Specialty Pharmaceutical market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Antibody
Hormone
Growth Factors
Other
Market segment by Application can be divided into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
The key market players for global Specialty Pharmaceutical market are listed below:
Pfizer
Roche
Amgen
AbbVie
Novo Nordisk
Johnson & Johnson
Sanofi-Aventis
Merck
Eli Lilly
Novartis
3sbio
Changchun High Tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Innovent
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Specialty Pharmaceutical product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Specialty Pharmaceutical, with price, sales, revenue and global market share of Specialty Pharmaceutical from 2019 to 2022.
Chapter 3, the Specialty Pharmaceutical competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Specialty Pharmaceutical breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Specialty Pharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Specialty Pharmaceutical.
Chapter 13, 14, and 15, to describe Specialty Pharmaceutical sales channel, distributors, customers, research findings and conclusion, appendix and data source.
❖ レポートの目次 ❖
| ★調査レポート[世界の特殊医薬品市場2022年：市場規模予測（～2028年）] (コード：GIR22DC3938)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の特殊医薬品市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせ |
